Abstract
ObjectivesThe number of reported cases of multiresistant Mycoplasma genitalium (MG) is increasing globally. The aim of this study was to estimate the prevalence of macrolide and possible fluoroquinolone resistance-associated mutations...
Highlights
Mycoplasma genitalium (Mg) is an emerging sexually transmitted infection (STI) and its global burden of disease is not very well known so far.[1]
Prevalence varies among different risk populations – and is generally higher in men who have sex with men (MSM) and female sex workers compared to other heterosexual individuals
Around one quarter of the patients had more than one positive Mg result over the four years (22.6%; n=48/212), most of them (79.1%; n=38/48) were part of the Be-pre-exposure prophylaxis (PrEP)-ared study
Summary
Mycoplasma genitalium (Mg) is an emerging sexually transmitted infection (STI) and its global burden of disease is not very well known so far.[1]. A systematic review and meta-analysis up to 2017 found the prevalence of Mg to be 0.9% in pregnant women, 3.2% in MSM and 15.9% in female sex workers.[2] The prevalence of Mg in MSM, is, reaching 10% according to the most recent publications.[3,4,5,6] Mg is a cause of non-gonococcal urethritis in men and cervicitis in women, but Mg is frequently found in asymptomatic individuals.[5] The natural history and clinical consequences of asymptomatic Mg infections are still poorly understood and including Mg in screening programmes among high risk groups is, not recommended. Mg positive samples should be further analysed for the presence of macrolide resistance RAMs to tailor patient treatment and management.[7]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
